Category Archives: Biotechnology

Seventh Belarusian Investment Forum (2012)
Minsk played host to the Seventh Belarus Investment Forum on 15-16 November. The event gathered more than 500 participants: representatives of foreign corporations and international financial institutions. For two days Belarus #39; capital turned into a venue for a dialogue between foreign investors, networking, business negotiations and presentation of investment opportunities of Belarus, including those arising from the Single Economic Space of Belarus, Russia and Kazakhstan. The first day of the forum featured a session of the Foreign Investment Advisory Council chaired by Prime Minister of Belarus Mikhail Myasnikovich, presentation of Minsk #39; investment opportunities and the Startup Day. On the second day the forum participants attended roundtable sessions to discuss such important areas of investment cooperation as information and communication technologies, pharmaceutics and biotechnology industry, regional development, cooperation with international financial institutions.From:belarusvisionViews:0 0ratingsTime:04:20More inNews Politics

Go here to see the original:
Seventh Belarusian Investment Forum (2012) - Video

Company says it has made an invisibility cloak
A US company says it has made a camouflage material that makes its wearer invisible. Hyperstealth Biotechnology Corp, a Canadian camouflage design company, claims the technology, called Quantum Stealth, works by bending light waves around the wearer. "The material removes not only your visual, infrared (night vision) and thermal signatures but also the target #39;s shadow," Hyperstealth president and CEO Guy Cramer said in a statement on the company #39;s website. Mr Cramer said he could not reveal how the material bent light or show photos of it working "for reasons of security". Photos published on the website that are described as a "mock up" show a woman lying on grass draped in a material that looks exactly like the grass around her. Mr Cramer said the US military and two Canadian military groups had tested the material and could vouch for it working "without batteries, lights or mirrors". He also claimed to be working with the US military to develop the technology further. But don #39;t put one on your Christmas list just yet. Mr Cramer said he did not expect the material would be made available for sale to the public. "Not in the near future unless the military decided to release the technology and I don #39;t anticipate that will happen anytime soon.From:juxtaposingBinariesViews:547 2ratingsTime:00:23More inEntertainment

See the original post:
Company says it has made an invisibility cloak - Video

Liquid Crystal Pump 1
This is a dielectrically actuated liquid crystal (LC) pump ( blue droplets). It has the following advantages: simple structure, easy fabrication, compact size, high precision, low power consumption, and relatively fast response time. It is promising for applications in lens actuators, biotechnology, drug delivery, and other lab-on-a-chip devices For more information, please see our lastest publication on Lab chip. pubs.rsc.orgFrom:TT XuViews:1 0ratingsTime:00:06More inScience Technology

Read more here:
Liquid Crystal Pump 1 - Video

Liquid Crystal Pump 2
This is a dielectrically actuated liquid crystal (LC) pump ( blue droplets). In the voltage-on state, it can exert a pressure to displace a small volume of fluid ( transparent droplet ) on the opposite side of the chamber. The promising applications incluede: lens actuators, biotechnology, drug delivery, and other lab-on-a-chip devices. For more information, please see our lastest publication on Lab chip. pubs.rsc.orgFrom:TT XuViews:2 0ratingsTime:00:06More inScience Technology

Read more here:
Liquid Crystal Pump 2 - Video

PCT 2012: Wall Street Perspectives: Economic Outlook on Investment Areas Growth Opportunities
Publicly traded CROs have been playing a disappearing act. During the past eight years, 13 contract clinical research service providers that were formerly public companies have moved into the private equity markets. Behind the veil afforded by the private markets, CROs have far greater latitude to not only complete transactions that complement their capacity and expertise and permit a founder to exit, but also to pursue novel leading strategies that may ultimately redefine integrated drug development services in the future. CROs now double the global capacity of drug development professionals and play a critical and essential role in supporting pharmaceutical and biotechnology company R D operations. With a global perspective, this distinguished group of financial leaders offers multi-stakeholder perspectives on the industry #39;s key threats and opportunities. bull; Does a public to private switch gives CROs better chance to "fix" and transform themselves? bull; Assess the difference in strategies between PE owned CROs, Private CROs, and public CROs. What value, do PE firms bring to CROs? bull; Why are private equity firms increasing their investments in CROs? How valuation methodologies to they use to decide what companies to invest in? bull; Is there a conflict of interest in Private equity firms investing in pharma and investing in CROs? Presenters: Moderator: Ian Lauf, MBA, Global Sourcing Manager, Medical Clinical Trial Central Services, Boehringer Ingelheim Pharmaceuticals, Inc ...From:PartnershipsIIRViews:0 0ratingsTime:01:04:24More inScience Technology

View post:
PCT 2012: Wall Street

Gene X (2012) full movie.avi
This short movie has been made by a group of M. Sc Biotechnology students, as part of our "creativity assignment" for the Genetic Engineering subject. The work is purely fiction, and made only for entertainment. Do not try to find any scientific logic in the movie, just sit back, relax, watch, and enjoy!! Thanks!! - M. Sc Biotechnology (2011-13) VIT University, India PS- Feel free to comment your views on our humble effort..From:Subham BasuViews:0 0ratingsTime:27:29More inEducation

Go here to read the rest:
Gene X (2012) full movie.avi - Video